The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure
Shihui Fu,1,2,* Leixing Xie,2,* Dongyun Li,1,2 Ping Ye,1 Leiming Luo11Department of Geriatric Cardiology, 2Department of Cardiology and Hainan Branch, Chinese People’s Liberation Army General Hospital, Beijing, People’s Republic of China*These authors are joint first authorsObjec...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5e8caad79eda4857a1640fa99640240a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:5e8caad79eda4857a1640fa99640240a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:5e8caad79eda4857a1640fa99640240a2021-12-02T04:33:43ZThe predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure1178-1998https://doaj.org/article/5e8caad79eda4857a1640fa99640240a2015-01-01T00:00:00Zhttps://www.dovepress.com/the-predictive-capacity-and-additional-prognostic-power-of-n-terminal--peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Shihui Fu,1,2,* Leixing Xie,2,* Dongyun Li,1,2 Ping Ye,1 Leiming Luo11Department of Geriatric Cardiology, 2Department of Cardiology and Hainan Branch, Chinese People’s Liberation Army General Hospital, Beijing, People’s Republic of China*These authors are joint first authorsObjective: This study was conducted to research the prognostic utility of N-terminal pro-B-type natriuretic peptide (NT-proBNP), compare the utility of the Seattle Heart Failure Score (SHFS) with NT-proBNP, develop a risk-evaluation model based on NT-proBNP, assess the associations of NT-proBNP with patient characteristics, and screen for decisive factors of NT-proBNP in Chinese elderly with chronic heart failure (CHF).Patients and methods: There were 306 patients (≥60 years) with CHF chosen as study subjects. Each one received an assessment of NT-proBNP on serum. The end point was all-cause mortality during a mean follow-up period of 471 days.Results: Subjects had a median age of 85 (60–100) years, a median NT-proBNP of 1,743.4 pg/mL, and a median SHFS of 1.87. During the follow-up period, 104 deaths occurred. NT-proBNP was significantly related to mortality (odds ratio 1.603, 95% confidence interval 1.407–1.826; P<0.001) and the significance persisted after full adjustment (odds ratio 1.282, 95% confidence interval 1.103–1.489; P=0.001). Age, New York Heart Association class IV CHF, plasma albumin, and neutrophils/lymphocytes were also independent predictors for mortality (P<0.05 for all). NT-proBNP and the SHFS showed similar predictive capacities (0.736 versus 0.796, P=0.105). The addition of NT-proBNP to the SHFS (0.818 versus 0.796, P=0.168) generated marginal growth in the c-statistic. The model based on NT-proBNP consisting of all selected predictors in this study, including age, New York Heart Association class IV CHF, plasma albumin, neutrophils/lymphocytes, and NT-proBNP, had a moderately higher c-statistic compared with the SHFS (0.846 versus 0.796, P=0.066). NT-proBNP was bound with the SHFS (r=0.500, P<0.001). Characteristics regarding general condition, inflammation, and cardiac and renal function were the decisive factors of NT-proBNP (P<0.05 for all).Conclusion: As a comprehensive representation of the patient characteristics described earlier, NT-proBNP values provided significant prognostic power similar to the SHFS in Chinese elderly with CHF. A novel model based on NT-proBNP could offer help for risk stratification.Keywords: NT-proBNP, prognosis, chronic heart failure, elderlyFu SXie LLi DYe PLuo LDove Medical PressarticleNT-proBNPPrognosisChronic heart failureElderlyGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 359-365 (2015) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
NT-proBNP Prognosis Chronic heart failure Elderly Geriatrics RC952-954.6 |
| spellingShingle |
NT-proBNP Prognosis Chronic heart failure Elderly Geriatrics RC952-954.6 Fu S Xie L Li D Ye P Luo L The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure |
| description |
Shihui Fu,1,2,* Leixing Xie,2,* Dongyun Li,1,2 Ping Ye,1 Leiming Luo11Department of Geriatric Cardiology, 2Department of Cardiology and Hainan Branch, Chinese People’s Liberation Army General Hospital, Beijing, People’s Republic of China*These authors are joint first authorsObjective: This study was conducted to research the prognostic utility of N-terminal pro-B-type natriuretic peptide (NT-proBNP), compare the utility of the Seattle Heart Failure Score (SHFS) with NT-proBNP, develop a risk-evaluation model based on NT-proBNP, assess the associations of NT-proBNP with patient characteristics, and screen for decisive factors of NT-proBNP in Chinese elderly with chronic heart failure (CHF).Patients and methods: There were 306 patients (≥60 years) with CHF chosen as study subjects. Each one received an assessment of NT-proBNP on serum. The end point was all-cause mortality during a mean follow-up period of 471 days.Results: Subjects had a median age of 85 (60–100) years, a median NT-proBNP of 1,743.4 pg/mL, and a median SHFS of 1.87. During the follow-up period, 104 deaths occurred. NT-proBNP was significantly related to mortality (odds ratio 1.603, 95% confidence interval 1.407–1.826; P<0.001) and the significance persisted after full adjustment (odds ratio 1.282, 95% confidence interval 1.103–1.489; P=0.001). Age, New York Heart Association class IV CHF, plasma albumin, and neutrophils/lymphocytes were also independent predictors for mortality (P<0.05 for all). NT-proBNP and the SHFS showed similar predictive capacities (0.736 versus 0.796, P=0.105). The addition of NT-proBNP to the SHFS (0.818 versus 0.796, P=0.168) generated marginal growth in the c-statistic. The model based on NT-proBNP consisting of all selected predictors in this study, including age, New York Heart Association class IV CHF, plasma albumin, neutrophils/lymphocytes, and NT-proBNP, had a moderately higher c-statistic compared with the SHFS (0.846 versus 0.796, P=0.066). NT-proBNP was bound with the SHFS (r=0.500, P<0.001). Characteristics regarding general condition, inflammation, and cardiac and renal function were the decisive factors of NT-proBNP (P<0.05 for all).Conclusion: As a comprehensive representation of the patient characteristics described earlier, NT-proBNP values provided significant prognostic power similar to the SHFS in Chinese elderly with CHF. A novel model based on NT-proBNP could offer help for risk stratification.Keywords: NT-proBNP, prognosis, chronic heart failure, elderly |
| format |
article |
| author |
Fu S Xie L Li D Ye P Luo L |
| author_facet |
Fu S Xie L Li D Ye P Luo L |
| author_sort |
Fu S |
| title |
The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure |
| title_short |
The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure |
| title_full |
The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure |
| title_fullStr |
The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure |
| title_full_unstemmed |
The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure |
| title_sort |
predictive capacity and additional prognostic power of n-terminal pro-b-type natriuretic peptide in chinese elderly with chronic heart failure |
| publisher |
Dove Medical Press |
| publishDate |
2015 |
| url |
https://doaj.org/article/5e8caad79eda4857a1640fa99640240a |
| work_keys_str_mv |
AT fus thepredictivecapacityandadditionalprognosticpowerofnterminalprobtypenatriureticpeptideinchineseelderlywithchronicheartnbspfailure AT xiel thepredictivecapacityandadditionalprognosticpowerofnterminalprobtypenatriureticpeptideinchineseelderlywithchronicheartnbspfailure AT lid thepredictivecapacityandadditionalprognosticpowerofnterminalprobtypenatriureticpeptideinchineseelderlywithchronicheartnbspfailure AT yep thepredictivecapacityandadditionalprognosticpowerofnterminalprobtypenatriureticpeptideinchineseelderlywithchronicheartnbspfailure AT luol thepredictivecapacityandadditionalprognosticpowerofnterminalprobtypenatriureticpeptideinchineseelderlywithchronicheartnbspfailure AT fus predictivecapacityandadditionalprognosticpowerofnterminalprobtypenatriureticpeptideinchineseelderlywithchronicheartnbspfailure AT xiel predictivecapacityandadditionalprognosticpowerofnterminalprobtypenatriureticpeptideinchineseelderlywithchronicheartnbspfailure AT lid predictivecapacityandadditionalprognosticpowerofnterminalprobtypenatriureticpeptideinchineseelderlywithchronicheartnbspfailure AT yep predictivecapacityandadditionalprognosticpowerofnterminalprobtypenatriureticpeptideinchineseelderlywithchronicheartnbspfailure AT luol predictivecapacityandadditionalprognosticpowerofnterminalprobtypenatriureticpeptideinchineseelderlywithchronicheartnbspfailure |
| _version_ |
1718401122406760448 |